Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sho Okamoto

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
World Neurosurgery|January 7, 2022
Risk Factors for Cerebral Infarction Early After Revascularization in Children Younger than 5 Years with Moyamoya DiseaseYoshio Araki, Kenji Uda, Kinya Yokoyama, et al.
Neurosurgical Review|October 31, 2021
Challenging direct bypass surgery for very young children with moyamoya disease: technical notesYoshio Araki, Kenji Uda, Kinya Yokoyama, et al.
Internal Medicine (Tokyo, Japan)|September 21, 2022
Diffuse Large B-cell Lymphoma Involving an Abundant Infiltration of T Follicular Helper CellsKeitaro Ishii, Kazuharu Kamachi, Sho Okamoto, et al.
Neurosurgical Review|January 8, 2021
Postoperative stroke and neurological outcomes in the early phase after revascularization surgeries for moyamoya disease: an age-stratified comparative analysisYoshio Araki, Kinya Yokoyama, Kenji Uda, et al.
Journal of Neurosurgery. Case Lessons|September 21, 2022
Paradoxical symptomatic cerebral blood flow decreases after combined revascularization surgery for patients with pediatric moyamoya disease: illustrative caseYoshio Araki, Kinya Yokoyama, Kenji Uda, et al.
Journal of Neuro-Oncology|August 2, 2003
Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptorSyuntaro Takasu, Toshitada Takahashi, Sho Okamoto, et al.
Internal Medicine (Tokyo, Japan)|July 2, 2023
Type II Cryoglobulinemic Membranoproliferative Glomerulonephritis Caused by Mucosa-associated Lymphoid Tissue LymphomaAyano Sugihara, Hiroshi Ureshino, Masatora Yamasaki, et al.
Neurosurgical Review|March 23, 2022
Changes in cerebral blood flow in the postoperative chronic phase after combined cerebral revascularization for moyamoya disease with ischaemic onsetYoshio Araki, Takashi Mamiya, Naotoshi Fujita, et al.
Annals of Hematology|November 27, 2019
Clinical impact of the CONUT score in patients with multiple myelomaSho Okamoto, Hiroshi Ureshino, Keisuke Kidoguchi, et al.
Magnetic Resonance in Medical Sciences : MRMS : an Official Journal of Japan Society of Magnetic Resonance in Medicine|March 17, 2022
Effect of Temporal Sampling Rate on Estimates of the Perfusion Parameters for Patients with Moyamoya Disease Assessed with Simultaneous Multislice Dynamic Susceptibility Contrast-enhanced MR ImagingTomohiro Takamura, Shoko Hara, Tadashi Nariai, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
World Neurosurgery|January 7, 2022
Risk Factors for Cerebral Infarction Early After Revascularization in Children Younger than 5 Years with Moyamoya DiseaseYoshio Araki, Kenji Uda, Kinya Yokoyama, et al.
Neurosurgical Review|October 31, 2021
Challenging direct bypass surgery for very young children with moyamoya disease: technical notesYoshio Araki, Kenji Uda, Kinya Yokoyama, et al.
Internal Medicine (Tokyo, Japan)|September 21, 2022
Diffuse Large B-cell Lymphoma Involving an Abundant Infiltration of T Follicular Helper CellsKeitaro Ishii, Kazuharu Kamachi, Sho Okamoto, et al.
Neurosurgical Review|January 8, 2021
Postoperative stroke and neurological outcomes in the early phase after revascularization surgeries for moyamoya disease: an age-stratified comparative analysisYoshio Araki, Kinya Yokoyama, Kenji Uda, et al.
Journal of Neurosurgery. Case Lessons|September 21, 2022
Paradoxical symptomatic cerebral blood flow decreases after combined revascularization surgery for patients with pediatric moyamoya disease: illustrative caseYoshio Araki, Kinya Yokoyama, Kenji Uda, et al.
Journal of Neuro-Oncology|August 2, 2003
Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptorSyuntaro Takasu, Toshitada Takahashi, Sho Okamoto, et al.
Internal Medicine (Tokyo, Japan)|July 2, 2023
Type II Cryoglobulinemic Membranoproliferative Glomerulonephritis Caused by Mucosa-associated Lymphoid Tissue LymphomaAyano Sugihara, Hiroshi Ureshino, Masatora Yamasaki, et al.
Neurosurgical Review|March 23, 2022
Changes in cerebral blood flow in the postoperative chronic phase after combined cerebral revascularization for moyamoya disease with ischaemic onsetYoshio Araki, Takashi Mamiya, Naotoshi Fujita, et al.
Annals of Hematology|November 27, 2019
Clinical impact of the CONUT score in patients with multiple myelomaSho Okamoto, Hiroshi Ureshino, Keisuke Kidoguchi, et al.
Magnetic Resonance in Medical Sciences : MRMS : an Official Journal of Japan Society of Magnetic Resonance in Medicine|March 17, 2022
Effect of Temporal Sampling Rate on Estimates of the Perfusion Parameters for Patients with Moyamoya Disease Assessed with Simultaneous Multislice Dynamic Susceptibility Contrast-enhanced MR ImagingTomohiro Takamura, Shoko Hara, Tadashi Nariai, et al.
Pageof 7